A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.

CONCLUSIONS: For patients with advanced ovarian cancer undergoing primary cytoreductive surgery, ANH appears to reduce allogenic RBC transfusion rates versus historical controls without increasing perioperative complications. Further evaluation of the technique is warranted.
PMID: 30336947 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - October 15, 2018 Category: Cancer & Oncology Authors: Tanner EJ, Filippova OT, Gardner GJ, Long Roche KC, Sonoda Y, Zivanovic O, Fischer M, Chi DS Tags: Gynecol Oncol Source Type: research